ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

Clinical Takeaways in From Recent Key Trials in Pancreatic Cancer

Hani Babiker

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Ad…

2024 ASCO® Annual Meeting Insights Hub

J. Knox

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX v…

ecancer

J. Knox

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro i…

2024 ASCO® Annual Meeting Insights Hub

B. Weinberg

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Yale Cancer Center

J. Lacy

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

UCLA Health

Z. Wainberg

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials Includ…

Insights from 2023 ASCO® Annual Meeting

Y. Janjigian, S. Cytryn, S. Maron

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

Shubham Pant

Optimizing 1L Treatment for Metastatic Pancreatic Cancer: Evaluating…

Angelo Pirozzi

ASCO® 2024 Review: Clinically-Impactful Abstracts in Pancreatic Canc…

Nebraska Oncology Society

R. Safyan

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Total Health

D. Lin

Augmenting Standard Treatment Options in Pancreatic Cancer

Rachna Shroff

ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem + na…

ecancer

E. O’Reilly

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 NAPOL…

Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

Z. Wainberg

Clinical Implications & Highlights of Recent Pancreatic Cancer Trial…

Total Health

J. Kratz

Updates on Pancreatic Cancer Treatment

The University of Kansas Cancer Center

A. Kasi

Overcoming Clinical Barriers: Integrating Liposomal Irinotecan Into …

Massachusetts General Hospital Cancer Center

P. Pathak